Objectives-To evaluate the association between shear wave elastography parameters using virtual touch tissue imaging quantification (VTIQ) and the Ki-67 index in luminal-type breast cancer.
results to classify breast cancer into 4 subtypes: luminal A, luminal B, HER2-enriched, and basal-like subtypes. 2, 5 Each molecular subtype has shown varying risk for tumor progression, treatment response, and clinical outcomes. 6 Ki-67 is a proliferative cell marker, which expressed in all phases of the cell cycle except for the G0 stage. 7 It can be used to distinguish specific luminal subtypes and guide the choice of chemotherapy or hormonotherapy alone. 8 In addition, Ki-67 could predict breast cancer patients' clinical outcome and treatment response. [9] [10] [11] The higher Ki-67 index correlates with poorer prognosis and early recurrence of breast cancer. On the other hand, a lower Ki-67 index stands for a favorable prognosis and late recurrence of it. Nevertheless, the evaluation of the Ki-67 index is possible only after a core biopsy or surgery at present. Also, proper tissue handling of surgical specimens is critical for an assessment of the Ki-67 index. 12 It has been reported that a significant discordance of exists between specimens at preoperative biopsy and surgery, especially in ER 1 /luminal breast cancers. [13] [14] [15] [16] Thus, it would be important if it is possible to predict the Ki-67 index through a noninvasive method. Recently, several studies have explored the relationship of diffusion-weighted magnetic resonance-derived parameters such as apparent diffusion coefficient (ADC) or intravoxel incoherent motion with Ki-67 status. In a report of 86 patients with luminal-type invasive breast cancer, Mori et al 17 found that ADC showed perfect interobserver reliability and significant correlation with Ki-67. Molinari et al 18 reported similar results, but the agreement of ADC measurement was moderate. Shin and Kim 19 recently demonstrated that intravoxel incoherent motion rather than ADC is independently associated with the Ki-67 proliferation status in patients with ER-positive invasive breast cancer. However, magnetic resonance imaging is an expensive and time-consuming examination compared to ultrasonography.
Ultrasonography is the preferred and most readily available tool in routine clinical practice for breast screening in China. Shear wave elastography (SWE) is a reproducible ultrasound modality that enables quantitative assessment of tissue stiffness based on an estimation of the speed of a shear wave. 20 However, early elastography such as strain elastography relied on manual compression and decompression applied by the operator. 21 Manual precompression of the tissue changes the elasticity and may lead to variable elastographic results. 22 Recently, acoustic radiation force impulse imaging to elastography has arisen. The probe automatically emits a short-duration acoustic pulse and does not require examiner external compression, and thus overcomes the limitation of result variability and operator dependence. Conventional acoustic radiation force impulse of virtual touch tissue quantification still has some shortcomings 23 : It is not suitable for small lesions and extremely hard or soft tissues because of the fixed region of interest (ROI) and the limited measurement range. In addition, the imaging quality is hard to assess sometimes because of inappropriate placement of ROI in the lesion. With the improvement of technique, the current virtual touch tissue imaging quantification (VTIQ) of SWE has overcome the aforementioned limitations. VTIQ as a new elastography method is highly reliable and reproducible 24, 25 . To our knowledge, there has been no study reporting the value of VTIQ in assessing the Ki-67 status of patients with ER-positive breast cancer.
Therefore, the purpose of the current study was to explore the relationship between the 2 most common parameters of VTIQ: mean shear wave velocity (SWV mean ) and SWV ratio and the Ki-67 labeling index in the ER 1 /luminal-type breast cancer.
Materials and Methods

Ethics Statement
Written informed consent for their information to be used in the hospital database was obtained from each participant. The study protocol was approved by the Ethics Committee of the Sun Yat-Sen University Cancer Center and was conducted in accordance with the Declaration of Helsinki. 
Study Participants
Conventional Ultrasound and VTIQ Examinations
Conventional ultrasound (see Figure 1 -A) and elastography images were obtained using a Siemens Acuson S2000 device (Siemens Medical Solutions, Mountain View, CA) with a linear 9L4 transducer was used for VTIQ by an experienced radiologist who specializes in breast imaging and is also well trained in VTIQ. Patients were asked about their disease history before examination and were examined in the standard position with the appropriate arm elevated. Conventional linear arrays were used, as for standard gray scale examinations. The VTIQ elastography was then initiated using the same probe. The probe emits a low frequent longitudinal push pulse that generates transverse shear-wave propagation and causes minimal localized displacement. The time to peak displacement at each lateral location is defined as shear wave velocity. Because the velocity of shear wave propagation in the tissue is proportional to tissue stiffness, a color-coded map provides information on the tissue stiffness. [24] [25] [26] [27] VTIQ has several imaging modes. In VTIQ, shear wave quality mode shows colors from high (green) to intermediate (yellow) to low quality (red) (see Figure 1B) . SWV mode displays colors from high SWV (red) to intermediate SWV (yellow or green) to low SWV (blue) (see Figure 1C) . To obtain the most optimal and reproducible SWV measurement, the SWV mode ROI was placed on the site that shows green areas on shear wave quality mode and red areas on SWV mode. VTIQ quantitatively measures the transverse SWV in meters per second within the ROI. When the SWV was given as "high" by the software, suggesting the velocity exceeded the upper limit of the VTIQ system, high was recorded as 10 meters per second. Each lesion and adjacent tissue was measured 3 times. The SWV mean and SWV ratio were calculated. All data were recorded and saved to the imaging machine for further analysis.
Statistical Analysis
The correlations of SWV mean , SWV ratio, and clinicopathologic parameters with THE Ki-67 labeling index were analyzed by using the t test for normally distributed variables and Mann-Whitney U test for nonnormally distributed variables. All patients were divided into 2 groups (high or low Ki-67 group) according to the cutoff value of 14%. Univariate and multivariate analyses were performed for the prognostic factors using the logistic regression. To estimate the optimal low/high Ki-67 labeling index thresholds (Youden's indices) and to evaluate the diagnostic performance for predicting high Ki-67 status, ROC analysis was performed. All statistical analyses were performed using statistical software (SPSS version 13.0; IBM Corporation, Armonk, NY). Statistical significance was set at P < .05 (2-tailed).
Results
The high Ki-67 group had faster SWV mean (P 5 .003), greater SWV ratio (P 5 .024), higher histologic grade (P 5 .003), axillary lymph node involvement (P 5 .003), and lymphovascular invasion (P 5 .007) compared to the low Ki-67 group. The size of the invasive tumor (P 5 .373), histologic type (P 5 0.247), P53 (P 5 .543), PR (P 5 .544), and HER2 status (P 5 .146) were not significantly different between the 2 groups (P 5 .373). The comparisons of SWV mean , SWV ratio, and clinicopathologic data between the high and low Ki-67 groups are shown in Table 1 and Figure 2 .
ROC curve analysis for the differential diagnosis between the high and low Ki-67 groups displayed that Figure 3 .
The relationships between Ki-67 and the clinical and histopathologic parameters are listed in Table 2 . In univariate analysis, SWV mean (P 5 .005), SWV ratio (P 5 .029), histologic grade (P 5 .011), presence of axillary node metastasis (P 5 .004), and lymphovascular invasion (P 
Discussion
Ki-67, an essential marker for distinguishing luminal A from luminal B subtype breast cancer, is related to tumor progression, treatment response, and clinical outcomes. However, the evaluation of Ki-67 index is possible only after a core biopsy or surgery. Also, the sample acquisition, postacquisition treatment, and compositional differences, in addition to the demonstrated dilution effect, all may affect the assessment of Ki-67 expression between core biopsies and surgical samples. 15 Preoperative imaging markers as a noninvasive method to provide additional information of Ki-67 status may be useful for accurate luminal classification and precise treatments. SWE enables quantitative assessment of lesion stiffness based on an estimation of the speed of a shear wave. 20 The stiffer the tissue is, the greater the SWV will be. In the present study, luminal type B demonstrated greater SWV mean and SWV ratio value compared to luminal type A. SWV mean using the VTIQ technique showed significant correlation and prognostic value for Ki-67 in luminal-type breast cancer, although the specificity in ROC analysis is low. This finding was consistently significant even after adjusting other clinicopathologic parameters and receptor status in a multiple logistic regression analysis. Our results suggest that determination of SWV mean values may help refine the assessment of tumor proliferation state, which would be beneficial for accurate classification and individual treatment.
In recent years, some studies have been conducted to evaluate the relationship between tumor stiffness measured by conventional strain elastography and molecular subtypes of breast cancer. Chang et al 28 evaluated 377 patients with invasive breast cancer and the available mean stiffness values (kPa) and qualitative color scores. They found that invasive cancer with aggressive prognostic features has higher mean stiffness values compared with cancers with good prognostic features. Similarly, in a report of 166 invasive breast cancers in 152 women, Youk et al 29 also demonstrated invasive breast cancers, with poor prognostic features showed higher mean elasticity values than those of good prognosis, whereas no immunohistochemical profile was independently associated with the mean elasticity. However, Figure 2 . SWV mean (A) and SWV ratio (B) for the low Ki-67 and high Ki-67. 30 reported an aggressive phenotype that appears to have lower maximum and mean stiffness in patients with invasive breast cancer. The different results may result from disease itself heterogeneous nature and the manually forced measured imaging method. In addition, selection of the ROI may be affected by subjective factors. In this study, we found that high Ki-67 status had faster SWV mean using the VTIQ method than low Ki-67 status. Furthermore, SWV mean is independently associated with Ki-67 both in univariate and multivariate analysis. Our results imply that VTIQ examination may provide the potential in evaluating the tumor proliferation status in patients with luminal-subtype breast cancer.
Ganau et al
Among the multiple parameters suggested for stiffness evaluation, quantitative mean stiffness values have been reported to be the highest reliability. 31 Recently, 2 retrospective studies reported the relation between mean stiffness and the different tumor subtypes. 28, 29 In this study, we showed that both SWV mean and SWV ratio were positively associated with Ki-67 at univariate analysis. However, on multivariate logistic regression analysis, only SWV mean remained as an independent prognostic factor for high Ki-67, which may imply that the SWV of the lesion itself is more able to reflect the lesion proliferative state rather than the combination of the SWV of the lesion and adjacent tissues. When calculating the area under the ROC for measured values, the best value to differentiate high Ki-67 versus low Ki-67 was SWV mean , which had the sensitivity and specificity for the cutoff value of 3.99 meters per second, sensitivity of 94%, and specificity of 40.6%. The relatively low specificity may just reflect the heterogeneity of breast cancer. In addition, the time and method of tissue handling of surgical specimens may cause a decreased level of the Ki-67 expression, leading to the relatively low specificity.
The underlying mechanisms between tumor stiffness and the Ki-67 status may be due to the vascular characteristics of tumors with high Ki-67. Tumor tissue stiffness is a characteristic of interactions among tumor cells, stromal cells, and extracellular matrix and was considered as the representative feature of the tumor microenvironment. 32, 33 The microenvironment of tumor cells is associated with tumor carcinogenesis and progression. 34 Higher stiffness was observed in hypervascular and poorly differentiated lesions than in hypovascular lesions. 35 In an animal model using colon cancer, mechanical properties of stiffness were correlated with tumor cellularity and microvessel density. 36 Ki-67 expression can be considered a representative marker of cellularity, explaining the high stiffness, as observed on faster SWV mean . However, whether SWV mean can be used for direct biopsy of most suspicious areas to improve concordance of specimens at preoperative biopsy and surgery still need further research to confirm.
Although our study shows the significant association between the SWV mean and Ki-67 index in patients with luminal-type breast cancer, the retrospective nature and relatively small sample size from a single center should be acknowledged as potential limitations. Further studies with larger numbers of patients are needed. However, the ultrasound measurements were acquired prospectively as part of our routine clinical practice by 1 experienced breast radiologist with more than 10 years of experience with breast sonography. In addition, selection of the ROI may be affected by subjective factors. Thus, automated ROI selection in the stiffest portion should be developed for the objective evaluation of VTIQ parameters. Another important problem is that there is still no uniform standardization of the immunohistochemical panel to define a proliferation index.
In conclusion, the SWV mean by the VTIQ technique is independently associated with Ki-67 status in patients with ER 1 /luminal-type breast cancer. This finding may suggest a potential role of VTIQ examination in evaluating the tumor proliferation status in such patients. However, considering its low specificity in our participants and the heterogeneous nature of the tumor itself, whether VTIQ examination could accurately reflect the tumor proliferation status and more specifically the Ki-67 index in patients with luminal-type breast cancer would need further study with a larger sample size to confirm.
